Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 16, Issue 1, Pages 35-52Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrd.2016.193
Keywords
-
Funding
- National Natural Science Foundation of China [81530043, 81330046]
- Ministry of Science and Technology of China [2015CB964500]
- Scientific Innovation Project of the Chinese Academy of Science [XDA01040100]
- Suzhou Science and Technology Program [SZS201616]
- Shanghai Rising-Star Program [14QA1404200]
- Youth Innovation Promotion Association research fund from the Chinese Acadmey of Sciences [2060206]
- Department of Science and Technology of Jiangsu Province research fund [BE2016671]
Ask authors/readers for more resources
Mesenchymal stem cells, also known as mesenchymal stromal cells (MSCs), exist in many tissues and are known to actively migrate to sites of tissue injury, where they participate in wound repair. Tumours can be considered wounds that never heal and, in response to cues from a tumour, MSCs are continuously recruited to and become integral components of the tumour microenvironment. Recently, it has become apparent that such tumour-associated MSCs (TA-MSCs) have an active role in tumour initiation, promotion, progression and metastasis. In this Review, we discuss recent advances in our understanding of the pathogenic role of TA-MSCs in regulating the survival, proliferation, migration and drug resistance of tumour cells, as well as the influence of MSCs on the immune status of the tumour microenvironment. Moreover, we discuss therapeutic approaches that target TA-MSC upstream or downstream modulators or use MSCs as vehicles for the delivery of tumoricidal agents. It is anticipated that new insights into the functions of TA-MSCs will lead to the development of novel therapeutic strategies against tumours.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available